SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-007765
Filing Date
2018-04-06
Accepted
2018-04-06 16:15:49
Documents
5
Period of Report
2018-05-24
Effectiveness Date
2018-04-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A vktx-def14a_20180524.htm DEF 14A 642014
2 GRAPHIC g201804052345227984984.jpg GRAPHIC 3485
3 GRAPHIC g201804052345229944985.jpg GRAPHIC 3485
4 GRAPHIC g201804052345307714987.jpg GRAPHIC 2953844
5 GRAPHIC g201804052345307174986.jpg GRAPHIC 136313
  Complete submission text file 0001564590-18-007765.txt   4907206
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37355 | Film No.: 18743385
SIC: 2834 Pharmaceutical Preparations